Form D · Biotechnology
Combinent BioMedical Systems, Inc.
Lexington, MA · CIK 0001400033
Offering snapshot reported Oct 1, 2012 · SEC filing
- Reported sold
- $600K Offering amount: $600K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 24, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 1, 2012 | Initial | $600,000 | No comparison | 2 | SEC filing |
| Jan 4, 2012 | Initial | $750,000 | No comparison | 3 | SEC filing |
| Dec 29, 2010 | Initial | $1,021,267 | No comparison | 4 | SEC filing |
| Sep 29, 2010 | Initial | $500,000 | No comparison | 3 | SEC filing |
| Dec 16, 2009 | Initial | $500,346 | No comparison | 3 | SEC filing |
| May 7, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-184827
Source: Form D, filed Oct 1, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Carl Berke | Director |
| Sena K. Biswas | Director |
| Rohan Hastie | Director |
| Peter Lanciano | Director, Executive |
| Robert Langer | Director |
| John Ledoux | Executive |
| Joel Sussman | Executive |
| Tom Umbel | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
420 Bedford Street Suite 240
Lexington, MA, 02420
Lexington, MA, 02420